These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11367044)

  • 1. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender difference in Nevirapine-associated rash.
    Proj Inf Perspect; 1999 Apr; (27):11. PubMed ID: 11366728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevirapine hypersensitivity.
    Popovic M; Shenton JM; Chen J; Baban A; Tharmanathan T; Mannargudi B; Abdulla D; Uetrecht JP
    Handb Exp Pharmacol; 2010; (196):437-51. PubMed ID: 20020271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
    Raffi F; Lewden C; Chêne G
    AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573
    [No Abstract]   [Full Text] [Related]  

  • 11. Nevirapine in children.
    Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects. Severe nevirapine rash found more likely in women than men.
    TreatmentUpdate; 2001; 12(8):7. PubMed ID: 12132442
    [No Abstract]   [Full Text] [Related]  

  • 13. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
    Steel-Duncan JC; Pierre R; Gabay L; Christie CD
    West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.
    Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE
    AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.
    Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F
    J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine-associated Stevens-Johnson syndrome.
    Warren KJ; Boxwell DE; Kim NY; Drolet BA
    Lancet; 1998 Feb; 351(9102):567. PubMed ID: 9492778
    [No Abstract]   [Full Text] [Related]  

  • 18. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
    Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
    J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
    Bundow D; Rosoff L; Aboulafia DM
    AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.